Patent · US Active

Inhibitors of 11β-hydroxysteroid dehydrogenase type 1

US8383629B2 · kind B2 · utility

3Cited by

6References

27Claims

0Family size

Assignee

Vitae Pharmaceuticals, LLC · US

Inventors

David A. Claremon · Audubon, US
Colin M. Tice · Ambler, US
Yuanjie Ye · Ambler, US
Suresh B. Singh · Kendall Park, US
Wei He · Audubon, US
Wei Zhao · North Potomac, US
Robert D. Simpson · Wilmington, US

Key dates

Filing date	Feb 26, 2009
Grant date	Feb 26, 2013
Priority date	—
Expiry date	Feb 26, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D221/20
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to novel compounds of the Formulae I or II and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof which are useful for the therapeutic treatment of diseases associated with the modulation or inhibition of 11 β-HSD 1 in mammals. Formula (I).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.